Shares of Merck KGaA (OTCMKTS:MKGAF - Get Free Report) hit a new 52-week low during trading on Thursday . The stock traded as low as $140.01 and last traded at $146.54, with a volume of 1464 shares. The stock had previously closed at $141.90.
Wall Street Analysts Forecast Growth
Separately, The Goldman Sachs Group raised Merck KGaA to a "strong-buy" rating in a report on Thursday, September 19th.
Read Our Latest Stock Analysis on MKGAF
Merck KGaA Price Performance
The company has a debt-to-equity ratio of 0.27, a current ratio of 1.31 and a quick ratio of 0.84. The firm has a market capitalization of $18.94 billion, a P/E ratio of 22.37 and a beta of 0.96. The company's 50 day moving average price is $154.10 and its 200 day moving average price is $169.33.
Merck KGaA Company Profile
(
Get Free Report)
Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company's Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.
Featured Articles
Before you consider Merck KGaA, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Merck KGaA wasn't on the list.
While Merck KGaA currently has a "Strong Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
